UNRESECTABLE ADRENAL CORTICAL CARCINOMA

Clinical trials for UNRESECTABLE ADRENAL CORTICAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new UNRESECTABLE ADRENAL CORTICAL CARCINOMA trials appear

Sign up with your email to follow new studies for UNRESECTABLE ADRENAL CORTICAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Two-Pronged attack on rare, tough cancer

Disease control Recruiting now

This study is for people with advanced adrenocortical cancer, a rare and aggressive cancer of the adrenal gland. It aims to see if combining a targeted drug (cabozantinib) with an immunotherapy drug (cemiplimab) works better to control the cancer and keep it from growing than the…

Matched conditions: UNRESECTABLE ADRENAL CORTICAL CARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

UNRESECTABLE ADRENAL CORTICAL CARCINOMA

Get alerted when new UNRESECTABLE ADRENAL CORTICAL CARCINOMA trials appear

Two-Pronged attack on rare, tough cancer